Sphere Fluidics

Activities: Manufacturing Analysis

Trending Articles

  1. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  2. Amgen invests $1bn into new US drug manufacturing facility The site will be the CDMO's second drug substance manufacturing facility in North Carolina, and will boost its presence in the US pharmaceutical market
  3. Reckitt expands US OTC manufacturing footprint with North Carolina facility The site in Wilson will be responsible for producing Mucinex® branded tablets and liquids, which are designed as over the counter (OTC) medicines for cold and flu symptoms
  4. Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme AI-driven approach promises a new class of depression treatment
  5. Pharma Packaging and Labelling Forum 27–28 May 2025 | Conference | Basel, Switzerland

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Design & Build

Sphere Fluidics unveils Cyto-Mine Chroma to enhance single-cell analysis

New platform offers multiplexing capabilities and accelerates biotherapeutic discovery and development
Analysis

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells
Analysis

Sphere Fluidics appoints Curtis Nicholson as Director of Sales: EMEA

Curtis will lead the expansion of the company's sales and customer support activities
Analysis

Sphere Fluidics appoints Dale Levitzke as CEO

Dale Levitzke joins as Dr Frank F. Craig, current CEO and co-founder, announces his retirement
Analysis

Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics

Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success
Manufacturing

Sphere Fluidics appoints Dr Graeme Daniels as Vice President of Sales and Marketing

Appointment to senior leadership team strengthens the Company’s plans for continued growth to advance its commercial ambitions
Manufacturing

Sphere Fluidics' platform chosen by Biosyntia for screening capabilities

Platform selected to accelerate precision fermentation workflows, to support more sustainable and cost-effective manufacturing for active ingredients in vitamins and bioactives
Subscribe now